ArticleBMC genomics2024

Upregulation of CALD1 predicted a poor prognosis for platinum-treated ovarian cancer and revealed it as a potential therapeutic resistance target.

Wei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.